lik066
Showing 1 - 11 of 11
Obese Patients With Non-alcoholic Steatohepatitis (NASH) Trial in Worldwide (LIK066, Placebo)
Completed
- Obese Patients With Non-alcoholic Steatohepatitis (NASH)
- LIK066
- Placebo
-
Baton Rouge, Louisiana
- +14 more
Oct 7, 2021
Renal Impairment Trial in Orlando (LIK066)
Completed
- Renal Impairment
- LIK066
-
Orlando, FloridaNovartis Investigative Site
Dec 9, 2020
Elevated Body Mass Index Trial in Lincoln (LIK066, Placebo)
Completed
- Elevated Body Mass Index
- LIK066
- Placebo
-
Lincoln, NebraskaNovartis Investigative Site
Dec 9, 2020
Obesity Trial in Lincoln (LIK066, Carbohydrate 50%, Carbohydrate 25%)
Completed
- Obesity
- LIK066
- +6 more
-
Lincoln, NebraskaNovartis Investigative Site
Dec 9, 2020
Polycystic Ovary Syndrome Trial in Germany, United States (LIK066, Placebo)
Completed
- Polycystic Ovary Syndrome
- LIK066
- Placebo
-
Springfield, Missouri
- +4 more
Dec 9, 2020
Type 2 Diabetes (T2DM) Trial in Miami (LIK066, Placebo)
Completed
- Type 2 Diabetes Mellitus (T2DM)
- LIK066
- Placebo
-
Miami, FloridaNovartis Investigative Site
Dec 11, 2020
Diabetes and Heart Failure Trial in Worldwide (LIK066, Placebo, Empagliflozin)
Terminated
- Diabetes Mellitus and Heart Failure
- LIK066
- +2 more
-
Huntsville, Alabama
- +105 more
Aug 9, 2019
Type 2 Diabetes Trial in Chula Vista (LIK066, Placebo)
Completed
- Type 2 Diabetes Mellitus
- LIK066
- Placebo
-
Chula Vista, CaliforniaNovartis Investigative Site
Jan 22, 2015
Type 2 Diabetes Trial (LIK066, Sitagliptin, Placebo)
Withdrawn
- Type 2 Diabetes Mellitus
- LIK066
- +2 more
- (no location specified)
Apr 2, 2014